Dimension Therapeutics (DMTX) Tops Q1 EPS by 19c

Dimension Therapeutics (NASDAQ: DMTX) reported Q1 EPS of ($0.38), $0.19 better than the analyst estimate of ($0.57). Revenue for the quarter came in at $2.21 million versus the consensus estimate of $2.24 million.

For earnings history and earnings-related data on Dimension Therapeutics (DMTX) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Silexion Therapeutics (SLXN) Tops Q2 EPS by 793c
• Hydrofarm Holdings Group, Inc. (HYFM) Misses Q2 EPS by 134c